Skip to main content
Signal8

Hecht Peter M

SEC insider (Form 3/4/5 filer). CIK 0001478485. Director & 10% Owner at Cyclerion Therapeutics, Inc. (CYCN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in CAMBRIDGE, MA.

Companies Hecht Peter M has filed insider reports for

  • Cyclerion Therapeutics, Inc. (CYCN): Director, 10% Owner
Hecht Peter M profile photo

Hecht Peter M

CIK: 0001478485

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cyclerion Therapeutics, Inc. logo
CYCN

Cyclerion Therapeutics, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Cyclerion Therapeutics, Inc. logo
    CYCN

    Cyclerion Therapeutics, Inc.

    Jul 16, 2026
    Conversion
    Direct
    351K shares-
  • Cyclerion Therapeutics, Inc. logo
    CYCN

    Cyclerion Therapeutics, Inc.

    Mar 25, 2025
    Award
    Direct
    181.8K shares at avg. $2.75$500K

1-2 of 2